1st Quarter - Report

IPOLICY SOLUTIONS for ASSOCIATION FOR MOLECULAR PATHOLOGY

Firm
Client
Income
$42,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Medical/Disease Research/Clinical Labs MED

No bill number, Verifying Accurate Leading-Edge IVCT Development (VALID) Act Coverage No bill number, Verified Innovative Testing in American Laboratories (VITAL) Act

LobbyistCovered position, as disclosed
MEGAN ANDERSON BROOKS —
JENNIFER RACHEL LEIB Fellow, Senate Committee on Health, Education, Labor, and Pensions

Contacted: Centers For Disease Control & Prevention (CDC); SENATE; HOUSE OF REPRESENTATIVES

Copyright/Patent/Trademark CPT

U.S. Patent Act Sec. 101 Reforms

LobbyistCovered position, as disclosed
MEGAN ANDERSON BROOKS —
JENNIFER RACHEL LEIB Legislative Fellow, Committee on Health, Education, Labor, and Pensions

Contacted: HOUSE OF REPRESENTATIVES; Centers For Disease Control & Prevention (CDC); SENATE

Medicare/Medicaid MMM

S.236 - Tracking COVID-19 Variants Act H.R.1946 - To amend title XVIII of the Social Security Act to provide for Medicare coverage of multi-cancer early detection screening tests.

LobbyistCovered position, as disclosed
MEGAN ANDERSON BROOKS —
JENNIFER RACHEL LEIB Fellow, Senate Committee on Health, Education, Labor, and Pensions

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Centers For Disease Control & Prevention (CDC)

Bills named: S. 236 (117th), H.R. 1946 (117th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.